2006P-0271:
Amend Practice of Assessing the Performance of Medical Devices for
Determining in Vitro Susceptibility of Bacteria or Fungi to Included
CLSI
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Document #
|
| Received Date
|
| Filed
Date
|
| Submitter Code
|
| Submitter
|
| FR
Date
|
| FR
Page
|
| Comment Date
|
| Files
|
| Remarks
|
|
|
|
|
| CP1
|
| 06/26/2006
|
| 06/26/2006
|
| Private Industry
|
| Clinical and Laboratory
Standards Institute
|
|
|
|
|
|
|
| Table
of Contents
|
|
|
|
| Signature:
|
| Robert Habig, PhD
|
|
|
| ACK1
|
| 06/27/2006
|
| 06/27/2006
|
| Federal Government
|
| FDA/DDM to Clinical
and Laboratory Standards Institute
|
|
|
|
|
|
|
| pdf
|
|
|
|
| Signature:
|
| Jennie C. Butler
| |
| C1
|
| 08/01/2006
|
| 07/28/2006
|
| Association
|
| Society of Infectious Diseases Pharmacists
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
| Signature:
|
| Thomas C Hardin, PharmD, MBA, FCC
|
|
| EC1
|
| 09/15/2006
|
| 09/14/2006
|
| Health Care Association
|
| Infectious Diseases Society of America
|
|
|
|
|
|
|
| htm
|
|
|
|
|
|
|
| Signature:
|
| Blaser, Martin
|
|
|
| EC2
|
| 09/19/2006
|
| 09/18/2006
|
| Health Care Association
|
| Infectious Diseases Society of America
|
|
|
|
|
|
|
| htm
|
|
|
|
|
| Signature:
|
| Blaser, Martin J.
|
|
|
|
|
| LET1
|
| 01/10/2007
|
| 01/10/2007
|
| Federal Government
|
| FDA to Clinical and Laboratory Standards Institute (CLSI)
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
|
|
|
| Signature:
|
| Murray M. Lumpkin, M.D.
|
|
|
| C2
|
| 01/11/2007
|
| 01/05/2007
|
| Health Care Association
|
| American Society for Microbiology (ASM)
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
| Signature:
|
| Ruth L. Berkelman, M.D. and Joseph
|
|
|
|
|
| PAV1
|
| 03/06/2007
|
| 03/06/2007
|
| Federal Government
|
| FDA to Clinical and Laboratory Standards Institute (CLSI)
|
|
|
|
|
|
|
| pdf
|
| and denied in part
|
|
|
|
|
|
|
|
| Signature:
|
| Murray M Lumpkin MD
|
|
|
|
|
|
|
Top | Up Page last updated:
March 20, 2007
|